Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis

PHASE4TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Persistence to Enbrel
Interventions
BEHAVIORAL

Personalized Patient Counselling

In the interventional cohort participants enrolled on the study will receive personalized patient counselling using the IMS-model based on the baseline BMQ results through a patient assistance program for patients on Enbrel (Etanercept) therapy.

Trial Locations (15)

R3A 1M3

Research Site, Winnipeg

E3B 6H5

Research Site, Fredericton

E2E 4J8

Research Site, Quispamsis

A1C 5B8

Research Site, St. John's

L8N 1Y2

Research Site, Hamilton

K7L 2W7

Research Site, Kingston

L5M 2V8

Research Site, Mississauga

K1S 1C2

Research Site, Ottawa

K9J 2V4

Research Site, Peterborough

H2L 1S6

Research Site, Montreal

H3T 1Y3

Research Site, Montreal

G1V 3M7

Research Site, Québec

G5L 8W1

Research Site, Rimouski

J1H 5N4

Research Site, Sherbrooke

G8Z 1Y2

Research Site, Trois-Rivières

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY